Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Martin Gutierrez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Feasibility and Acceptability of Symptom Management Research in Black Advanced Lung Cancer Patients
Conley, C. C., Mossman, B., Aduloju, A., Billini, O. M., Slossar, J., Khoudary, A., Rodriguez, J. D., Kim, C., Wheeley, J., Gutierrez, M. & Derry-Vick, H., Mar 1 2026, In: Journal of Pain and Symptom Management. 71, 3, p. e220-e230Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access -
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer: AMBER Part 2B
Davar, D., Eroglu, Z., Milhem, M., Becerra, C., Gutierrez, M., Ribas, A., Di Pace, B., Wang, T., Zhang, H., Ghosh, S., Yanamandra, N., Borgovan, T., Srivats, S., Waszak, A., Dhar, A. & Lorusso, P., Aug 15 2025, In: Clinical Cancer Research. 31, 16, p. 3443-3451 9 p.Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access -
First-in-human phase i open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors
Gutierrez, M. E., Tang, S. C., Powderly, J. D., Balmanoukian, A. S., Hoyle, P. E., Dong, Z., Cheng, L., Gong, X., Janik, J. E., Bourayou, N. & Hamid, O., Jul 1 2025, In: Oncologist. 30, 7, oyaf144.Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access -
First-in-human phase i open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors
Powderly, J. D., Gutierrez, M. E., Balmanoukian, A. S., Hoyle, P. E., Dong, Z., Cheng, L., Chen, X., Janik, J. E., Bourayou, N. & Hamid, O., Jul 1 2025, In: Oncologist. 30, 7, oyaf136.Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access -
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study
Ku, G., Haag, G. M., Park, H., Lam, V. K., George, T. J., Kim, S. S., Gutierrez, M., Shankaran, V., Stein, S., Denlinger, C. S., Elimova, E., Nagrial, A., He, A. R., Sawyer, M. B., Yoon, H. H., Geva, R., Starr, J., Curigliano, G., Golan, T. & von Moos, R. & 8 others, , Feb 2025, In: ESMO Open. 10, 2, 104107.Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access